Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function alleles

Georg Michlits1, Julian Jude2, Matthias Hinterndorfer2

  • 1Institute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna BioCenter (VBC), Vienna, Austria.

Nature Methods
|June 10, 2020
PubMed

Insights

CRISPR-Cas9 screens rely on effective gene knockout. This study introduces a new score predicting CRISPR-Cas9 mutagenesis, improving loss-of-function allele generation for essential gene studies.

Area of Science:

  • Genomics
  • Molecular Biology
  • Biotechnology

Background:

  • CRISPR-Cas9 screens are vital for systematic gene function analysis.
  • Screen quality, especially in negative-selection screens, hinges on generating loss-of-function alleles.
  • Observed dropout efficiencies in essentialome screens exceed predictions based on frameshift mutations alone.

Purpose of the Study:

  • To investigate the factors contributing to high-efficiency loss-of-function allele generation in CRISPR-Cas9 screens.
  • To develop a predictive tool that enhances the selection of single-guide RNAs (sgRNAs) for effective gene knockout.

Main Methods:

  • Performed essentialome screens in cancer cell lines and embryonic stem cells using optimized workflows.
  • Analyzed the impact of in-frame mutations on protein function, correlating it with amino acid composition and conservation.
  • Integrated protein features, sgRNA activity predictors, and indel formation predictors into a novel scoring system.

Main Results:

  • Superior effect sizes in CRISPR-Cas9 screens are primarily driven by in-frame mutations impacting protein function.
  • A predictive model, the Vienna Bioactivity CRISPR score, was developed by integrating protein features and sgRNA performance metrics.
  • This new score demonstrates superior performance compared to existing tools in predicting effective sgRNAs for loss-of-function allele generation.

Conclusions:

  • In-frame mutations play a critical role in CRISPR-Cas9 mediated gene knockout efficiency.
  • The Vienna Bioactivity CRISPR score offers an improved method for selecting sgRNAs, leading to more reliable loss-of-function alleles.
  • This tool enhances the precision and success rate of CRISPR-Cas9 screens for functional genomics research.

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.5K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
37.7K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.5K